Chemomab Therapeutics Stock Forecast

Sell candidate since Nov 03, 2025 Loss -7.14%

The Chemomab Therapeutics Ltd. stock price fell by -2.26% on the last day (Monday, 17th Nov 2025) from $2.66 to $2.60. During the last trading day the stock fluctuated 10.35% from a day low at $2.51 to a day high of $2.77. The price has fallen in 5 of the last 10 days and is down by -7.14% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -12 thousand shares and in total, 84 thousand shares were bought and sold for approximately $219.12 thousand.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 27.07% during the next 3 months and, with a 90% probability hold a price between $2.07 and $4.90 at the end of this 3-month period.

CMMB Signals & Forecast

There are few to no technical positive signals at the moment. The Chemomab Therapeutics Ltd. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.63 and $2.99. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, October 08, 2025, and so far it has fallen -25.71%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Chemomab Therapeutics Ltd. stock

Chemomab Therapeutics Ltd. finds support from accumulated volume at $2.58 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.260 between high and low, or 10.35%. For the last week the stock has had daily average volatility of 7.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CMMB) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Chemomab Therapeutics Ltd. to open at $2.63, and during the day (based on 14 day Average True Range), to move between $2.49 and $2.71, which gives a possible trading interval of +/-$0.228 (+/-9.16%) up or down from last closing price. If Chemomab Therapeutics Ltd. takes out the full calculated possible swing range there will be an estimated 9.16% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.58 (0.77%) than the resistance at $2.63 (1.15%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Chemomab Therapeutics Ltd. stock A Buy?

The Chemomab Therapeutics Ltd. stock holds several negative signals and despite the positive trend, we believe Chemomab Therapeutics Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.182 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $2.63 ( 1.03%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk